ATE485052T1 - Kovalenter faktor vii-gewebefaktor-komplex - Google Patents

Kovalenter faktor vii-gewebefaktor-komplex

Info

Publication number
ATE485052T1
ATE485052T1 AT07727577T AT07727577T ATE485052T1 AT E485052 T1 ATE485052 T1 AT E485052T1 AT 07727577 T AT07727577 T AT 07727577T AT 07727577 T AT07727577 T AT 07727577T AT E485052 T1 ATE485052 T1 AT E485052T1
Authority
AT
Austria
Prior art keywords
factor
covalent
complex
factor vii
tissue
Prior art date
Application number
AT07727577T
Other languages
English (en)
Inventor
Henrik Ystergaard
Ole Olsen
Anders Klarskov Petersen
Henning Ralf Stennicke
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE485052T1 publication Critical patent/ATE485052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT07727577T 2006-04-07 2007-03-30 Kovalenter faktor vii-gewebefaktor-komplex ATE485052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112358 2006-04-07
PCT/EP2007/053105 WO2007115953A1 (en) 2006-04-07 2007-03-30 Covalent factor vii-tissue factor complex

Publications (1)

Publication Number Publication Date
ATE485052T1 true ATE485052T1 (de) 2010-11-15

Family

ID=36781437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727577T ATE485052T1 (de) 2006-04-07 2007-03-30 Kovalenter faktor vii-gewebefaktor-komplex

Country Status (8)

Country Link
US (1) US20110040073A1 (de)
EP (1) EP2007417B1 (de)
JP (1) JP5759102B2 (de)
CN (1) CN101466400B (de)
AT (1) ATE485052T1 (de)
DE (1) DE602007009956D1 (de)
ES (1) ES2353084T3 (de)
WO (1) WO2007115953A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2127640A1 (de) * 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
US9345113B2 (en) 2009-06-24 2016-05-17 Koninklijke Philips N.V. Method and device for programming a microcontroller
US20120321607A1 (en) * 2010-01-28 2012-12-20 Novo Nordisk Health Care Ag Factor VII Fusion Polypeptides
US20150044195A1 (en) * 2012-03-30 2015-02-12 Novo Nordisk Healthcare Ag FVIIa-sTF complexes exhibiting exosite-mediated super activity
US10202595B2 (en) 2012-06-08 2019-02-12 Bioverativ Therapeutics Inc. Chimeric clotting factors
EP2858659B1 (de) 2012-06-08 2019-12-25 Bioverativ Therapeutics Inc. Prokoagulationsverbindungen
EP2906693A1 (de) 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Gerinnungsfaktor-vii-polypeptide
KR20180031775A (ko) 2015-08-12 2018-03-28 셀 머신스, 인크. 긴 반감기 응집 복합체와 관련된 방법 및 조성물
AU2020259982A1 (en) 2019-04-17 2021-10-28 Novo Nordisk A/S Bispecific antibodies
CN114836503B (zh) * 2022-04-29 2023-08-25 江苏祈瑞医药科技有限公司 一组具有肝损伤保护作用的乳清蛋白肽、高f值寡肽及其制备方法和应用
CN116041537B (zh) * 2022-09-26 2025-09-19 山西博鑫生物科技有限公司 一种重组组织因子rhTF突变体及其应用
WO2025168826A1 (en) 2024-02-08 2025-08-14 Hemab Aps Methods of treating coagulopathy
CN117860874B (zh) * 2024-03-12 2024-07-02 正大天晴药业集团南京顺欣制药有限公司 重组人凝血因子VIIa的药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
WO1997020939A1 (en) * 1995-12-01 1997-06-12 Genentech, Inc. TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS
DK0979281T3 (da) * 1997-05-02 2005-11-21 Genentech Inc Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele
PL204285B1 (pl) * 2000-02-11 2009-12-31 Bayer Healthcare Llc Koniugat polipeptydowy, polipeptyd, sekwencja nukleotydowa, wektor ekspresyjny, komórka gospodarz, sposób wytwarzania koniugatu polipeptydowego, środek farmaceutyczny i zastosowanie koniugatu polipeptydowego
CA2441986A1 (en) * 2001-03-27 2002-10-03 Massachusetts Institute Of Technology Methods and products related to fgf dimerization
ES2376694T3 (es) * 2001-09-27 2012-03-16 Novo Nordisk Health Care Ag Polipã‰ptidos del factor vii de coagulaciã“n humano.
CA2461292A1 (en) * 2001-10-02 2003-04-10 Genentech, Inc. Apo-2 ligand variants and uses thereof
KR101080587B1 (ko) * 2002-05-01 2011-11-04 바이엘 파마 악티엔게젤샤프트 항응고제로서의 신규 조직 인자 표적화된 항체
AU2003242507A1 (en) * 2002-07-12 2004-02-02 Novo Nordisk A/S A tissue factor binding immunoconjugate comprising factor viia
EP1673453A2 (de) * 2003-10-07 2006-06-28 Novo Nordisk Health Care AG Hybridmoleküle mit faktor vii/viia-aktivität

Also Published As

Publication number Publication date
JP2009532048A (ja) 2009-09-10
CN101466400A (zh) 2009-06-24
ES2353084T3 (es) 2011-02-25
US20110040073A1 (en) 2011-02-17
WO2007115953A1 (en) 2007-10-18
DE602007009956D1 (de) 2010-12-02
JP5759102B2 (ja) 2015-08-05
EP2007417B1 (de) 2010-10-20
CN101466400B (zh) 2014-06-25
EP2007417A1 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
ATE485052T1 (de) Kovalenter faktor vii-gewebefaktor-komplex
DE602007004086D1 (de) Acrylierte hyaluronsäure
MY145652A (en) Process for the manufacture of dihydropteridinones
MX2011001679A (es) Derivados de flavina.
EP2589651A3 (de) Zusammensetzungen und Verfahren mit Serinproteasevarianten
CA119816S (en) Manikin chest shield
IN2012DN00580A (de)
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
MX2010010660A (es) Nuevos complejos de rutenio como catalizadores para reacciones de metatesis.
AU319229S (en) Hand held vacuum body
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
EP2132013A4 (de) Durch biotemplating hergestellte dünne metallnanodrähte
PT2382198E (pt) Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc
UA91053C2 (en) Inhibitors of cytosolic phospholipase a2
UA115221C2 (uk) Спосіб активації та кон'югації фактора коагуляції
MX2009003459A (es) Derivados de 2,3,3-trimetilciclopent-3-encarbaldehido utiles como odorantes.
ATE444990T1 (de) Spritzbare akustikmassen
WO2010111257A3 (en) Targeted schiff base complexes
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
SG129432A1 (en) Automated generation of multi-dimensional structure activity and structure property relationships
ATE496941T1 (de) Herstellung von insulinkonjugaten
UA91733C2 (ru) Способ получения кристаллической формы орлистата
FR2898895B1 (fr) Cyclopeptide a activite anti-cancereuse derive du collagene de type iv
ATE454144T1 (de) Behandlung von malignen neoplasien
NZ700085A (en) Wnt antagonists and methods of treatment and screening

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties